These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15636137)
1. [Naso-subcutaneous application of the polycomponent vaccine VP-4 for the treatment of patients with bronchial asthma and chronic obstructive bronchitis]. Antonova LP; Markova TP; Kurbatova EA Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):36-40. PubMed ID: 15636137 [TBL] [Abstract][Full Text] [Related]
2. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously]. Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974 [TBL] [Abstract][Full Text] [Related]
3. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis]. Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948 [TBL] [Abstract][Full Text] [Related]
4. [The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms]. Egorova NB; Efremova VN; Kurbatova EA; Kuz'mina LA Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):96-101. PubMed ID: 9460881 [No Abstract] [Full Text] [Related]
5. [Multicomponent vaccine VP-4 in the therapy of allergic diseases]. Osipova GL Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):36-42. PubMed ID: 12630351 [TBL] [Abstract][Full Text] [Related]
7. [The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms]. Mansurova NL; Egorova NB; Kaverina KG; Poliachenko VM; Lobova EA Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):39-41. PubMed ID: 1882605 [TBL] [Abstract][Full Text] [Related]
8. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever]. Poddubikova AM; Kostinov MP Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399 [TBL] [Abstract][Full Text] [Related]
9. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods]. Efremova VN; Poliachenko VM; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812 [TBL] [Abstract][Full Text] [Related]
10. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally]. Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073 [TBL] [Abstract][Full Text] [Related]
11. [The mutagenicity of a new multicomponent vaccine made from the antigens of Klebsiella pneumoniae, Staphylococcus aureus, Proteus vulgaris and Escherichia coli]. Volgareva GM; Tolcheev IuD; Egorova NB; Mansurova NL; Silin AM; Anpilogova OR Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):50-2. PubMed ID: 1887711 [TBL] [Abstract][Full Text] [Related]
12. [Protective activity of a cell-free Klebsiella vaccine in infection in mice caused by Streptococcus pneumoniae serotypes]. Kurbatova EA; Egorova NB; Krasnoproshina LI; Rodionychev EA; Mansurova NL Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):60-5. PubMed ID: 3887815 [TBL] [Abstract][Full Text] [Related]
13. [Humoral immune response in patients with bronchopulmanory infections to immunotherapy]. Slatinova OV; Mokronosova MA; Skhodova SA; Krasnoproshina LI Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):49-53. PubMed ID: 11548259 [TBL] [Abstract][Full Text] [Related]
15. [An evaluation of the protective activity of a multicomponent vaccine made from opportunistic microorganisms in the oral method of immunization in a model of local staphylococcal infection]. Efremov VN; Poliachenko VM Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):73-6. PubMed ID: 8067121 [TBL] [Abstract][Full Text] [Related]
16. [ChemicaL and immunochemical characteristics of antigenic preparations from Staphylococcus aureus and Klebsiella pneumoniae as the components for an associated vaccine]. Shagam NL; Efremova VN; Kurbatova EA; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):51-5. PubMed ID: 3140544 [TBL] [Abstract][Full Text] [Related]
17. [The effect of immunotherapy with the VP-4 multicomponent vaccine in children with frequent acute respiratory diseases and obstructive bronchitis]. Obol'skaia NM Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):60-3. PubMed ID: 10876897 [TBL] [Abstract][Full Text] [Related]
18. [The effect of immunotherapy with cell-free vaccines made from the antigens of opportunistic microorganisms on the dynamics of DNA antibody formation]. Egorova NB; Shagam NL; Vaneeva NP; Efremova VN; Osipova GL; Masiukova SA; Kuz'mina LA Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):45-7. PubMed ID: 1801489 [TBL] [Abstract][Full Text] [Related]
19. [The immunotherapy of bronchial asthma with a multicomponent vaccine administered intranasally and orally]. Chuchalin AK; Balabolkin II; Egorova NB; Efremova VN; Osipova GL; Kurbatova EA; Stepushina MA Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):84-8. PubMed ID: 9304340 [TBL] [Abstract][Full Text] [Related]
20. Agglutinin response to bacterial infection in acute exacerbations of chronic bronchitis. Nicholls AC; Pease PE; Green ID J Clin Pathol; 1975 Apr; 28(4):279-83. PubMed ID: 805163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]